OMGA - Omega Therapeutics GAAP EPS of -$0.44 beats by $0.19 revenue of $0.14M March, 10 2022 08:30 AM Omega Therapeutics Inc. Omega Therapeutics press release (NASDAQ:OMGA): Q4 GAAP EPS of -$0.44 beats by $0.19. Revenue of $0.14M. For further details see: Omega Therapeutics GAAP EPS of -$0.44 beats by $0.19, revenue of $0.14M